184 related articles for article (PubMed ID: 19299075)
1. Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells.
You H; Jin J; Shu H; Yu B; De Milito A; Lozupone F; Deng Y; Tang N; Yao G; Fais S; Gu J; Qin W
Cancer Lett; 2009 Jul; 280(1):110-9. PubMed ID: 19299075
[TBL] [Abstract][Full Text] [Related]
2. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.
Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S
Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667
[TBL] [Abstract][Full Text] [Related]
3. LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump.
Fan S; Niu Y; Tan N; Wu Z; Wang Y; You H; Ke R; Song J; Shen Q; Wang W; Yao G; Shu H; Lin H; Yao M; Zhang Z; Gu J; Qin W
Oncogene; 2013 Mar; 32(13):1682-90. PubMed ID: 22580606
[TBL] [Abstract][Full Text] [Related]
4. pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines.
Martínez-Zaguilán R; Raghunand N; Lynch RM; Bellamy W; Martinez GM; Rojas B; Smith D; Dalton WS; Gillies RJ
Biochem Pharmacol; 1999 May; 57(9):1037-46. PubMed ID: 10796074
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional role of vacuolar H(+)-ATPase in human hepatocellular carcinoma.
Xu J; Xie R; Liu X; Wen G; Jin H; Yu Z; Jiang Y; Zhao Z; Yang Y; Ji B; Dong H; Tuo B
Carcinogenesis; 2012 Dec; 33(12):2432-40. PubMed ID: 22962303
[TBL] [Abstract][Full Text] [Related]
6. Vacuolar H+ -ATPase c protects glial cell death induced by sodium nitroprusside under glutathione-depleted condition.
Byun YJ; Lee SB; Lee HO; Son MJ; Kim HS; Kwon OJ; Jeong SW
J Cell Biochem; 2011 Aug; 112(8):1985-96. PubMed ID: 21433058
[TBL] [Abstract][Full Text] [Related]
7. Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells.
Hinton A; Sennoune SR; Bond S; Fang M; Reuveni M; Sahagian GG; Jay D; Martinez-Zaguilan R; Forgac M
J Biol Chem; 2009 Jun; 284(24):16400-16408. PubMed ID: 19366680
[TBL] [Abstract][Full Text] [Related]
8. Silencing of TMSG1 enhances metastasis capacity by targeting V-ATPase in breast cancer.
Zi Y; Zhao W; Zhou J; He H; Xie M
Int J Clin Exp Pathol; 2015; 8(2):1312-20. PubMed ID: 25973015
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors may reduce tumour resistance.
De Milito A; Fais S
Expert Opin Pharmacother; 2005 Jun; 6(7):1049-54. PubMed ID: 15957961
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
11. Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition.
Hraběta J; Belhajová M; Šubrtová H; Merlos Rodrigo MA; Heger Z; Eckschlager T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575682
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of vacuolar H+ -ATPase c on hydrogen peroxide-induced cell death in C6 glioma cells.
Byun YJ; Lee SB; Kim DJ; Lee HO; Son MJ; Yang CW; Sung KW; Kim HS; Kwon OJ; Kim IK; Jeong SW
Neurosci Lett; 2007 Oct; 425(3):183-7. PubMed ID: 17845832
[TBL] [Abstract][Full Text] [Related]
13. The role of endolysosomal trafficking in anticancer drug resistance.
Hussein NA; Malla S; Pasternak MA; Terrero D; Brown NG; Ashby CR; Assaraf YG; Chen ZS; Tiwari AK
Drug Resist Updat; 2021 Jul; 57():100769. PubMed ID: 34217999
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer.
Song T; Jeon HK; Hong JE; Choi JJ; Kim TJ; Choi CH; Bae DS; Kim BG; Lee JW
Cancer Res Treat; 2017 Jul; 49(3):595-606. PubMed ID: 27669706
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase.
Pereira CS; Guedes JP; Gonçalves M; Loureiro L; Castro L; Gerós H; Rodrigues LR; Côrte-Real M
Oncotarget; 2016 Sep; 7(38):62144-62158. PubMed ID: 27556694
[TBL] [Abstract][Full Text] [Related]
16. Tumor acidity, chemoresistance and proton pump inhibitors.
De Milito A; Fais S
Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.
Lee YY; Jeon HK; Hong JE; Cho YJ; Ryu JY; Choi JJ; Lee SH; Yoon G; Kim WY; Do IG; Kim MK; Kim TJ; Choi CH; Lee JW; Bae DS; Kim BG
Oncotarget; 2015 Oct; 6(33):35040-50. PubMed ID: 26418900
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A
Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274
[TBL] [Abstract][Full Text] [Related]
19. V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo.
Kubisch R; Fröhlich T; Arnold GJ; Schreiner L; von Schwarzenberg K; Roidl A; Vollmar AM; Wagner E
Int J Cancer; 2014 May; 134(10):2478-88. PubMed ID: 24166050
[TBL] [Abstract][Full Text] [Related]
20. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
